does bpc 157 help with bone healing Peptide Therapy for Pain Management and bpc 157 for broken bones

published data in Endocrinology showing the peptide's ability to reduce adipose tissue in ob/ob mice by 50% over 19 days without affecting lean mass or circulating IGF-1 [1]

No serious systemic ghk-cu side effects have been documented in peer-reviewed human studies at therapeutic doses

Kidneys not good for some reason which in a 16 yr old is concerning

In: Ohno S., Aoki K., Usui M., editors

Superior and Sustained Performance: Arthramid achieves 80-85% efficacy across multiple peer-reviewed studies Long-lasting Results: Clinical studies demonstrate sustained efficacy up to 2 years post-treatment Evidence-Based Efficacy: Double-blinded controlled studies confirm Arthramid outperforms triamcinolone steroid and hyaluronic acid Proven Safety Profile: Histopathology studies confirm successful joint integration and biocompatibility Robust Research Foundation: Results validated across six independent peer-reviewed studies spanning multiple research teams and geographical locations Unlike many joint treatments on the market, Arthramid is backed by a growing body of robust, real-world research, not just anecdotal outcomes